USPTO 2015–2025 USPTO PatentsView US Corporation

Medtronic Xomed, Inc.

USPTO PatentsView assignee record - 239 granted patents across 46 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Medtronic ranks #1,709 of 49,997 tracked US assignees by granted-patent volume, with 239 patents across 46 technology areas.

#1,709
of 49,997 US assignees by volume
Top 3%
by Innovation Score (61.9/100)
17.6
avg claims per patent
+22%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R1709 · US Corporation #1,709 · 239 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

  • GRANTS-MID 239 grants
  • TOP-DECILE #1,709/49,997
  • PHOTO-FINISH Entit Software
  • CPC-WIDE A61B · 46 areas
  • INNOV-STRONG 61.9/100
  • CLAIMS-RICH 17.6 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-UP +22% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Entit Software LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Medtronic’s 61.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Medtronic

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Medtronic's Innovation Score is 61.9/100 (top 3% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Medtronic?

Each dot is one of Medtronic’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Medtronic’s own 17.6 claims/patent is ABOVE the 15.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Medtronic vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 238.5239239.5240240.5241241.5 81012141618 Granted patents (volume) Avg claims / patent Southwire Company, LLC - 241, 15.56SouthwireArkray, Inc. - 240, 11.43ArkrayDana Heavy Vehicle Systems Group, LLC - 240, 16.42Dana Heavy Vehicl…Entit Software LLC - 239, 16.9Entit SoftwareNikkiso Co., Ltd. - 239, 10.62NikkisoTheravance Biopharma R&D IP, LLC - 239, 15.06Theravance Biopha…Vorwerk & Co. Interholding GMBH - 239, 9.84Vorwerk & Interho…ZKW Group GmbH - 239, 16.97ZKW GroupMedtronic Xomed, Inc. - 239, 17.57Medtronic Xomed
Medtronic vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Medtronic's grants concentrate

Medtronic Xomed, Inc. is a focused PatentsView assignee: 46 CPC subclasses with 80.3% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (38 grants) versus a trough of 18 in 2015. By volume, Medtronic sits between Southwire Company, LLC and ZKW Group GmbH.

Medtronic's three-year grant acceleration

From 2019–2021 to 2022–2024, Medtronic Xomed, Inc. moved from 66 to 84 grants (1.27x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #680. See the growth leaderboard.

Who files at Medtronic's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Medtronic holds 239 patents at rank #1,709, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Medtronic

By rank, the assignees closest to #1,709 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Medtronic's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Medtronic, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Medtronic ranks #102 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (62 here).

Similar claim depth

Nearest assignees by average claims per patent (17.6 here).

Medtronic's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

62 Top 3% higher than 97% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

10203040 20152016201720182019202020212022202320242025 13
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Medtronic Xomed, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 18 7.5%
2016 20 8.4%
2017 18 7.5%
2018 20 8.4%
2019 26 10.9%
2020 18 7.5%
2021 22 9.2%
2022 18 7.5%
2023 28 11.7%
2024 38 15.9%
2025partial year 13 5.4%

Which technologies does Medtronic Xomed, Inc. patent most?

Top 15 of 46 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Medtronic Xomed, Inc.'s patent record in context - here's where to go next.

  • Medtronic Xomed, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 80.3% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #1,709 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Medtronic Xomed, Inc. against Southwire Company, LLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 61.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.